Expression profiles for macrophage alternative activation genes in AD and in mouse models of AD
2006

Macrophage Activation in Alzheimer's Disease

Sample size: 76 publication 10 minutes Evidence: moderate

Author Information

Author(s): Carol A Colton, Ryan T Mott, Hayley Sharpe, Qing Xu, William E Van Nostrand, Michael P Vitek

Primary Institution: Duke University Medical Center

Hypothesis

Do microglia in Alzheimer's disease exhibit alternative activation states similar to peripheral macrophages?

Conclusion

The study suggests that immune cells in the brain show a mix of activation states, indicating a complex role in Alzheimer's disease.

Supporting Evidence

  • Microglia treated with IL-4 or IL-13 showed increased expression of alternative activation genes.
  • Significant increases in AGI, MRC1, and YM1 mRNA levels were observed in Tg-2576 mouse brains.
  • AD brain samples exhibited increased mRNA levels for TNFα, AGI, CHI3L1, and CHI3L2 compared to controls.
  • Both classical and alternative activation markers were present in AD brains, indicating a mixed activation state.

Takeaway

The brain's immune cells can act in different ways, sometimes helping to heal and other times causing inflammation, especially in Alzheimer's disease.

Methodology

Quantitative RT-PCR was used to identify gene expression profiles in microglia and brain samples from mouse models and Alzheimer's patients.

Potential Biases

Potential bias in sample selection and the interpretation of gene expression data.

Limitations

The study primarily focuses on gene expression without direct functional assays of macrophage activity.

Participant Demographics

The study included 47 Alzheimer's patients and 29 cognitively normal controls, with a mix of genders.

Statistical Information

P-Value

p<0.04

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1742-2094-3-27

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication